BioXcel Therapeutics Reports Financial Results for the Fourth Quarter and Full Year 2023

Go back to BioXcel Therapeutics Reports Financial Results for the Fourth Quarter and Full Year 2023
(NASDAQ: BTAI) Delayed: 0.07 --0 (-0%)
Previous Close $0.07    52 Week High
Open $0.07    52 Week Low
Day High $0.07    P/E N/A 
Day Low $0.07    EPS
Volume 9,277,797